BlackRock Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$6.27M Buy
228,628
+26,815
+13% +$736K 0.01% 1426
2016
Q3
$12.4M Buy
201,813
+34,025
+20% +$2.09M 0.02% 870
2016
Q2
$3.2M Buy
167,788
+11,825
+8% +$226K ﹤0.01% 1758
2016
Q1
$3.04M Buy
155,963
+11,492
+8% +$224K ﹤0.01% 1710
2015
Q4
$5.57M Sell
144,471
-30,135
-17% -$1.16M 0.01% 1327
2015
Q3
$5.61M Sell
174,606
-4,354
-2% -$140K 0.01% 1307
2015
Q2
$5.45M Buy
178,960
+27,867
+18% +$848K 0.01% 1424
2015
Q1
$2.01M Buy
151,093
+16,117
+12% +$214K ﹤0.01% 2018
2014
Q4
$1.95M Buy
134,976
+23,285
+21% +$337K ﹤0.01% 2050
2014
Q3
$2.36M Buy
111,691
+414
+0.4% +$8.74K ﹤0.01% 1874
2014
Q2
$3.32M Buy
111,277
+7,584
+7% +$226K ﹤0.01% 1695
2014
Q1
$2.49M Buy
103,693
+725
+0.7% +$17.4K ﹤0.01% 1876
2013
Q4
$2.1M Buy
102,968
+8,353
+9% +$170K ﹤0.01% 1983
2013
Q3
$4.47M Buy
94,615
+10,179
+12% +$481K 0.01% 1370
2013
Q2
$3.21M Buy
+84,436
New +$3.21M 0.01% 1510